HMGB1 and osteosarcoma: As a key regulator of autophagy, HMGB1 promotes drug resistance of a number of cancers including osteosarcoma (143), lung adenocarcinoma (144), and leukemia (145) by activating protective autophagy following pharmacotherapy.